Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hercules Technology Growth Capital (NY: HTGC )

19.41 -0.10 (-0.51%)
Streaming Delayed Price Updated: 2:16 PM EST, Dec 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hercules Technology Growth Capital

< Previous 1 2 3 4 Next >
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Recap: Hercules Capital Q1 Earnings
Via Benzinga
Expert Ratings for Hercules Capital
Via Benzinga
What 5 Analyst Ratings Have To Say About Hercules Capital
Via Benzinga
Hercules Capital: Dividend Insights
Via Benzinga
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
RingCentral, Alteryx, International Flavors & Fragrances And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows: 
Via Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
Mental health psychedelics biotech company COMPASS Pathways (NASDAQ: CMPS) received funding for its COMP360 Phase 3 program in Treatment-Resist 
Via Benzinga
Hercules Capital Stock: This Double-Digit Yielder’s Muscles Are Sagging
Hercules hasn’t cut the regular quarterly dividend since 2010. However, the supplemental dividend has been lowered as recently as March of this year. 
Via Talk Markets
The Tech Rally Shows You Need to Buy Stocks Others Hate
It is hard to believe that 2022 was a bear market for tech stocks, with steep price declines. A look at some numbers for a few stocks investors hated last year. 
Via Talk Markets
Expert Ratings for Hercules Capital
Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter: 
Via Benzinga
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch
Via Benzinga
Hercules Capital: A Specialized, High-Yield BDC That Benefits From Rising Rates
I have four Business Development Companies on my list of recommended stocks. The Fed’s interest rate hikes have proven to be a huge benefit for BDCs. With this in mind, Hercules Capital will continue... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
First Republic Bank, Bank of America And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
These Stocks Are On A Dividend Increase Bonanza
Today I want to provide a list of BDCs that have announced dividend increases and/or supplemental dividends and which ones to look at for your portfolio. 
Via Talk Markets
As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside
In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The... 
Via Benzinga
4 Analysts Have This to Say About Hercules Capital
Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Daily Stock Analysis: Hercules Capital Inc.
Hercules Capital Inc. is a small-cap asset management company operating in the financial services business sector. 
Via Talk Markets
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
Via Benzinga
The 2 Best Stocks For Even Higher Interest Rates
Even if the future is messy and it’s hard to guess what will happen, there are investment strategies that will get you through the next couple of years and beyond. Here are two stocks worth a closer... 
Via Talk Markets
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility... 
Via Benzinga
The 2 Best Stocks For The 2022 Recession
Let’s take a look at how this recession will affect the giant mega-cap companies that most investors follow, as well as some smaller companies operating in specific business niches. The difference will... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Earnings Preview For Hercules Capital
Hercules Capital (NYSE:HTGC) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Hercules... 
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
What 4 Analyst Ratings Have To Say About Hercules Capital
Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter: 
Via Benzinga
Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.